Roberta, Balestrino
Paolo, Barone
Massimo, Filippi http://orcid.org/0000-0002-5485-0479
Roberto, Erro
Article History
Received: 26 July 2021
Revised: 13 September 2021
Accepted: 14 September 2021
First Online: 18 September 2021
Change Date: 9 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00415-021-10923-w
Declarations
:
: RB declares no conflict of interest. PB received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie, and Acorda. FM is Editor-in-Chief of the Journal of Neurology and Associate Editor of Radiology, Human Brain Mapping and Neurological Sciences, received compensation for consulting services and/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries, and receives research support from Biogen Idec, Merck-Serono, Novartis and Roche. RE received royalties from the publication of “Paroxysmal Movement Disorders” (Springer, 2020) and honoraria for speaking from the Movement Disorder Society.
: Not applicable.
: Not applicable.
: Not applicable.